COVID-19 vaccines are disease-modifying, reduce chances of severe infection, mortality: ICMR chief

India's drug regulator has also granted permission for the restricted emergency use of the Russian COVID-19 vaccine Sputnik V with certain conditions.

published on : 13th April 2021

Three advanced facilities in AIIMS soon

AIIMS-Bhubaneswar has been sanctioned with three new diagnostic facilities by Indian Council of Medical Research (ICMR) and Department of Health Research. 

published on : 12th April 2021

ICMR appoints BP Acharya advisor to NARFBR

Acharya had served as the Special Chief Secretary in before retirement and also as the DG of MCRHRD Institute of Telangana.

published on : 11th April 2021

Nearly 40,000 fresh Covid-19 cases recorded in India, highest single-day spike in 2021

 The daily rise in infections (39,726) was the highest recorded in 110 days, while the death toll increased to 1,59,370 with 154 daily new fatalities, the data updated at 8 am showed.

published on : 19th March 2021

Unhealthy living pushing Indians to ‘silent killers’

Survey on non-communicable diseases finds less intake of fruit, veg and high salt usage.

published on : 6th March 2021

Covaxin effective against mutant virus strains: ICMR

According to him, a paper on Covaxin’s neutralisation potential against the UK strain has been accepted for publication.

published on : 20th February 2021

Clinical trials indicate India's vaccines will be effective against Covid-19 variants: ICMR

ICMR Director General Dr Bhargava pointed out that India was the fifth country in the world to isolate the Covid-19 virus as part of the efforts to develop a vaccine for the pandemic.

published on : 19th February 2021

South African Covid-19 strain detected in 4 returnees: Centre

India has also detected the Brazilian strain of the virus in one person, said ICMR director general Balram Bhargava.

published on : 16th February 2021

Centre earmarks Rs 6,995 crore for Odisha Railways, state 'unhappy'

The state government had demanded Rs 7,200 crore of which Rs 3,500 crore was for the pending projects and Rs 3,700 crore for new projects.

published on : 5th February 2021

Over 20 per cent of adults have antibodies against Covid-19 in India: ICMR sero-survey

The survey, based on the combined results from both the tests has estimated the average infection prevalence at about 25 per cent.

published on : 5th February 2021

Large proportion of India still vulnerable to Covid-19: ICMR serosurvey

The third national serosurvey by the ICMR has found that 21.5% of the population above 18 has antibodies against Covid-19.

published on : 4th February 2021

25% Indians now have antibodies against COVID-19, shows ICMR's latest serosurvey

The survey, whose findings are yet to be released, has estimated that the country's actual Covid-19 infection size is 30 crore.

published on : 31st January 2021

Bharat Biotech, SII approach DCGI for using COVID vaccine on those using blood thinners: ICMR DG

Responding to a query during a press conference, Balram Bhargava clarified that there is no contraindication in administering COVID vaccines to those who are on blood thinners such as aspirin.

published on : 28th January 2021

Phase-I trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study

Among those who received Covaxin, the study reported that only one serious adverse event was reported which was found to be unrelated to the vaccine

published on : 22nd January 2021

Can Covaxin work against new strain? ICMR studies

Experts say such experiment can only be in-vitro neutralisation data

published on : 9th January 2021
1 2 3 4 5 6 >